*St brand new: Hanfu holdings reduced its holdings of 2027000 shares on September 14

Stepping Into 2023 | Ten Investors' Insights into Opportunities and Challenges for Chinese

Many years from now, this generation will have aged and retired. We may imagine an elderly retiree sitting on a wheelchair pushed by the ‘bicentennial man’ or similar robot helper, admiring a holographic projection of the California Sunset, and sipping from a cup of biochemical coffee which prevents aging.

Pulnovo Medical: Chinese Medical Device Companies are Making Their Voices Heard Globally

‘Chinese medical device companies, represented by Pulnovo Medical, have always pursued medical innovation under the support of policies and capital. They have increasingly improved their technical innovation, strategic planning, and product competitiveness. Navigating the way through a dynamic, ever-changing market, Chinese medical device companies are making their voices heard in the global market.’

AI Protein Design Platform MoleculeMind Completed Over CNY 100 Mn Strategic Round Funding

Synthetic biology leader Cathay Biotech seeks a more efficient AI-driven manufacturing process

Compound Steep Pulse Device Developer REMD Nets Over CNY 100 Mn in Series A+

The leader in irreversible electroporation technology plans to expand the use of technology in various indications

BociMed Closed CNY 100 Mn in A New Financing Round

After this financing, BociMed will implement business restructuring and specify the focus of subsidiary and parent company